AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist.

Joel R Gever, Rothschild Soto, Robert A Henningsen, Renee S Martin, David H Hackos, Sandip Panicker, Werner Rubas, Ian B Oglesby, Michael P Dillon, Marcos E Milla, Geoffrey Burnstock, Anthony PDW Ford

2010
-
British Journal of Pharmacology

Share this publication: